The audit at Indrad plant of the company was carried out by the United States Food and Drug Administration (USFDA) in April.
from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2IKhS0K
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» USFDA makes 'certain' observations for Torrent Pharma's Indrad plant
0 comments:
Post a Comment